Clinical Stemcell Research Inc.


Practical application of DFAT super cell-derived culture supernatant.
This supernatant produces a variety of growth factors, regenerative factors, and cytokines during the DFAT cell culturing process.
These are extracted and used for therapies.
Thanks to the characteristics of DFAT cells, an abundance of nutrients can be extracted in large quantities.
We are performing research and development on these for therapies to regenerate blood vessels, hair, skin, intervetebral discs, alveolar bone, and more.
We anticipate development of a wide range of therapies and supplements .
As it is not a cell therapy, practical applications will be realized in the near future.


Company Profile

Company Name Clinical Stemcell Research Inc.
Headquarters Address 1-11-4 Hiroo, Shibuya, Tokyo
Executives Representative Director:Ryuji Sugawara
Director:Takaaki Tokunaga
Capital Stock 54,000,000 yen
Activities Practical application and commercialization of DFAT-derived supernatant
Primary Bank MUFG Bank

DFAT cells were used Treatment for small animals

Regenerative medicine What is DFAT cell?

What is DFAT-derived supernatant?

Copyright © Stemcell Holdings Limited. All Rights Reserved.
Powered by WordPress & BizVektor Theme by Vektor,Inc. technology.